Table 1. Clinical & biochemical characteristics for participants.
| Variable | SA | EU | T-test(p-value) |
|---|---|---|---|
| Total number | 26 | 29 | |
| Age (years) | 35.30 ± 11.10 | 32.20 ± 10.30 | 0.27 |
| Female (n) | 7 | 16 | 0.08 |
| Overweight/Obese (n) | 15 | 22 | |
| Systolic BP (mmHg) | 112.50 ± 10.20 | 110.80 ± 9.50 | 0.49 |
| Diastolic BP (mmHg) | 73.70 ± 9.00 | 73.10 ± 6.50 | 0.65 |
| Body composition & adiposity | |||
| BMI (kg/m2) | 26.20 ± 3.50 | 27.30 ± 5.20 | 0.39 |
| WHR | 0.89 ± 0.09 | 0.84 ± 0.07 | 0.016 |
| Fat mass (kg) | 23.90 ± 8.10 | 25.70 ± 13.10 | 0.53 |
| Fat mass % | 32.0 ± 9.20 | 32.20 ± 13.20 | 0.95 |
| Lean mass (kg) | 50.50 ± 9.50 | 51.90 ± 10.00 | 0.58 |
| Visceral adipose tissue area (cm2, N = 55) | 141.70 ± 15.10 | 66.00 ± 14.10 | 0.001 |
| Subcutaneous adipose tissue area (cm2, N = 38) | 219.10 ± 82.40 | 244.60 ± 105.00 | 0.31 |
| Intrahepatocellular fat % | 9.90 ± 1.70 | 2.50 ± 1.90 | 0.005 |
| Biochemical measurements | |||
| Fasting glucose (mmol/l) | 5.00 ± 0.55 | 4.80 ± 0.44 | 0.06 |
| Fasting insulin (pmol/l) | 8.80 ± 4.10 | 8.00 ± 5.80 | 0.26 |
| HOMA-IR | 2.45 ± 1.70 | 1.70 ± 1.30 | 0.07 |
| Cholesterol (mmol/l) | 4.60 ± 0.99 | 4.80 ± 1.05 | 0.43 |
| Triglycerides (mmol/l) | 1.57 ± 1.16 | 1.12 ± 0.60 | 0.06 |
| HDL (mmol/l) | 1.20 ± 0.27 | 1.39 ± 0.37 | 0.08 |
| LDL (mmol/l) | 2.70 ± 0.80 | 2.80 ± 0.80 | 0.58 |
| Apo B (mmol/l) | 0.91 ± 0.30 | 0.93 ± 0.29 | 0.80 |
SA = South Asian; EU = European; BMI = body mass index; WHR = waist-to-hip ratio; BP = blood pressure; HOMA-IR = Homeostatic model assessment-insulin resistance; HDL = high-density lipoprotein; LDL=low-density lipoprotein; Apo B = Apolipoprotein B; V02 max = maximal oxygen uptake.